The goal of finding clinically useful biomarkers to identify MCI patients at risk of developing Alzheimer’s disease has proved elusive with conflicting results reported by different centres. In Sweden, a large multicentre study has investigated the accuracy of CSF beta-amyloid(1-42), total tau protein (T-tau), and tau phosphorylated at position threonine 181 (P-tau) (Mattsson et al. JAMA 2009; 302: 385-393). Subscribe to read more It takes 30 sec…

…A number of recent studies have suggested that hyper- or hypothyroidism is associated with an increased risk of Alzheimer’s disease. Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…